Dermapharm Holding SE buy Prof
Summary
This prediction ended on 08.07.22 with a price of €51.00. The price of Dermapharm Holding SE has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.04%. Prof has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | -2.817% | -2.817% | -3.558% | -4.263% |
| iShares Core DAX® | -3,99 % | -2,81 % | 4,16 % | 51,38 % |
| iShares Nasdaq 100 | 0,35 % | -0,75 % | 9,47 % | 85,93 % |
| iShares Nikkei 225® | -3,85 % | 4,23 % | 28,36 % | 56,86 % |
| iShares S&P 500 | 0,30 % | 0,38 % | 6,14 % | 59,57 % |
Comments by Prof for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE


